Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Use of pramipexole in REM sleep behavior disorder: results from a case series.

Schmidt MH, Koshal VB, Schmidt HS.

Sleep Med. 2006 Aug;7(5):418-23. Epub 2006 Jul 3.

PMID:
16815751
2.

Lack of effects of pramipexole on REM sleep behavior disorder in Parkinson disease.

Kumru H, Iranzo A, Carrasco E, Valldeoriola F, Marti MJ, Santamaria J, Tolosa E.

Sleep. 2008 Oct;31(10):1418-21.

3.
4.

Rapid eye movement sleep behavior disorder.

Gugger JJ, Wagner ML.

Ann Pharmacother. 2007 Nov;41(11):1833-41. Epub 2007 Oct 9. Review.

PMID:
17925503
5.

The association between narcolepsy and REM behavior disorder (RBD).

Nightingale S, Orgill JC, Ebrahim IO, de Lacy SF, Agrawal S, Williams AJ.

Sleep Med. 2005 May;6(3):253-8.

PMID:
15854856
6.

A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.

Jama L, Hirvonen K, Partinen M, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2009 Jun;10(6):630-6. doi: 10.1016/j.sleep.2008.05.014. Epub 2009 Jan 25.

PMID:
19171500
7.

Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.

Partinen M, Hirvonen K, Jama L, Alakuijala A, Hublin C, Tamminen I, Koester J, Reess J.

Sleep Med. 2006 Aug;7(5):407-17. Epub 2006 Jul 3.

PMID:
16815748
8.

The effects of pramipexole in REM sleep behavior disorder.

Fantini ML, Gagnon JF, Filipini D, Montplaisir J.

Neurology. 2003 Nov 25;61(10):1418-20.

PMID:
14638967
9.

First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.

Manconi M, Ferri R, Zucconi M, Oldani A, Fantini ML, Castronovo V, Ferini-Strambi L.

Sleep Med. 2007 Aug;8(5):491-7. Epub 2007 May 18.

PMID:
17512780
10.

Effectiveness of pramipexole, a dopamine agonist, on rapid eye movement sleep behavior disorder.

Sasai T, Inoue Y, Matsuura M.

Tohoku J Exp Med. 2012 Mar;226(3):177-81.

11.

[Pramipexole therapy of restless legs syndrome].

Vida Z, Szakács Z.

Ideggyogy Sz. 2007 Jan 20;60(1-2):15-22. Hungarian.

PMID:
17432089
13.

REM sleep behaviour disorder: clinical profiles and pathophysiology.

Paparrigopoulos TJ.

Int Rev Psychiatry. 2005 Aug;17(4):293-300. Review.

PMID:
16194802
14.

Pramipexole in the management of restless legs syndrome: an extended study.

Silber MH, Girish M, Izurieta R.

Sleep. 2003 Nov 1;26(7):819-21.

PMID:
14655914
15.

The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.

Merlino G, Dolso P, Canesin R, Cancelli I, Valente M, Gigli GL.

Neuropsychobiology. 2006;54(3):195-200. Epub 2007 Feb 21.

PMID:
17314491
16.

Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases.

Olson EJ, Boeve BF, Silber MH.

Brain. 2000 Feb;123 ( Pt 2):331-9.

PMID:
10648440
17.

Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.

Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.

Sleep Med. 2008 Dec;9(8):874-81. doi: 10.1016/j.sleep.2008.09.001. Epub 2008 Oct 25.

PMID:
18952497
18.

REM sleep behavior disorder and narcolepsy.

Billiard M.

CNS Neurol Disord Drug Targets. 2009 Aug;8(4):264-70. Review.

PMID:
19689308
19.
20.

[Historical overview of REM sleep behavior disorder in relation to its pathophysiology].

Tachibana N.

Brain Nerve. 2009 May;61(5):558-68. Review. Japanese.

PMID:
19514516

Supplemental Content

Support Center